Quintiles has sold its minority interest in Invida, an Asia Pacific commercial solutions joint venture, to the Italy-based Menarini Group, which is acquiring Invida in its entirety. Invida was formed in 2006 by Quintiles; The Zuellig Group; and TLS Beta, an Asia investment company.

Invida provides biopharmaceutical product sales support in 13 markets in Asia Pacific; the Menarini Group is a privately held top-50 global biopharmaceutical company.

“As a result of this opportunity, we will pursue strategic expansion of our commercial solutions in Asia that are integrated with Quintiles’ global systems, capabilities and expertise, and optimize the breadth and depth of our offerings across our commercial, clinical, capital and consulting groups,” said Rich Pilnik, president of global commercial solutions, Quintiles. “We will continue to build from our existing commercial business in Japan, where Quintiles is the market leader in outsourced commercialization solutions.”